Clik here to view.
Data points to no age-related cutoff for mammogram screenings | RSNA 2016...
There is no clear cut-off age to stop breast cancer screening, according to new data from the largest-ever study on mammogram screening outcomes. Data from the study was presented this week at the...
View ArticleClik here to view.
InGeneron inks collaboration with German Accelerator Life Sciences
InGeneron said today that it landed a collaboration with the German Accelerator Life Sciences program, establishing an additional U.S. presence in Cambridge, Mass. The initiative is supported by the...
View ArticleClik here to view.
Scilex touts data for novel lidocaine patch
Sorrento Therapeutics (NSDQ:SRNE) subsidiary Scilex Pharmaceuticals said today that its lidocaine patch, ZTlido, met primary and secondary endpoints in a pivotal study comparing the patch to Endo...
View ArticleClik here to view.
Tricuspid repair firm 4Tech names Thoratec vet Ennen as CEO | Personnel Moves...
Transcatheter tricuspid heart valve repair device developer 4Tech said today it tapped former Thoratec interventional products GM Dr. Michael Ennen as its new prez & CEO, taking over for Carine...
View ArticleClik here to view.
Biotronik launches BioMonitor 2 subcutaneous heart monitor trial
Biotronik said today it enrolled the 1st patients in the BioInsight clinical study of its BioMonitor 2 heart monitor, which looks to investigate the feasibility implanting the BioMonitor 2 in office...
View ArticleClik here to view.
NeuroPace touts 7-year data on RNS neurostim therapy for epilepsy
NeuroPace today released 7-year follow-up data from a clinical trial of its RNS neurostimulation system designed to prevent epileptic seizures, touting an over-70% reduction in seizure frequency. The...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for December 5, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
FDA clears Kyocera Medical’s Initia hip implant
Implantable medical systems maker Kyocera Medical said today it won FDA 510(k) clearance for its Initia total hip implant system. The Japanese company’s Initia total hip system includes Bioceram Azul...
View ArticleClik here to view.
Researchers show drug, catheter combo speeds up labor delivery
Using the drug misoprostol in combination with a Foley balloon catheter to induce labor can lead to a speedier delivery, with women delivering several hours earlier than either method alone, according...
View ArticleClik here to view.
Usnic acid electrospun fibers demonstrate antibacterial properties
Researchers from the Institute of Materials Science in Juazeiro, Brazil have reported on the antibacterial properties of usnic acid, a strong lichen metabolite, encapsulated in electrospun fibers. The...
View ArticleClik here to view.
Invendo Medical wins CE Mark for Invendoscope SC200
Invendo Medical said today it won CE Mark approval in the European Union for its Invendoscope SC200, which it touts as the world’s 1st sterile, single-use colonoscope. The German company said its...
View ArticleClik here to view.
MedyMatch looks to future of stroke detection with AI platform launch
Artificial intelligence healthcare startup MedyMatch Technology said late last month its AI platform designed to detect intracranial hemorrhage or brain bleeds is now available for research. The...
View ArticleClik here to view.
2017 CDRH regulatory science priorities
The Center for Devices and Radiological Health (CDRH) recently issued its fiscal 2017 regulatory science priorities. The list repeats some of the points highlighted in its 2016 list, while surfacing...
View ArticleClik here to view.
Neovasc surges on early data for Tiara mitral valve implant
Neovasc (NSDQ:NVCN) said today that early clinical data on its Tiara transcatheter mitral valve replacement showed an 86% technical success rate and 100% freedom from mild, trace or absent paravalvular...
View ArticleClik here to view.
Sanofi throws hat in the ring with J&J’s in Actelion pursuit
Sanofi (NYSE:SNY) is reportedly considering a bid for Actelion Pharmaceuticals (VTX:ATLN), competing with an offer made to the Swiss biotech by Johnson & Johnson (NYSE:JNJ). Bloomberg reported...
View ArticleClik here to view.
Medtronic wins expanded CE Mark indication for Endurant II stent graft
Medtronic (NYSE:MDT) said today that it won an expanded CE Mark indication in the European Union for its Endurant II/IIs stent graft for treating abdominal aortic aneurysms. The expanded indication...
View ArticleClik here to view.
Egypt arrests 45 in organ smuggling ring
(Reuters) – Egypt has uncovered a network accused of illicit international trafficking in human organs, arresting 45 people and recovering millions of dollars in a dawn raid on Tuesday, the health...
View ArticleClik here to view.
Novo Nordisk joins Allergan in pledge to limit price hikes
Novo Nordisk (NYSE:NVO) president Jakob Riis said this week that the company will limit annual price hikes of its products’ list prices to single-digit percentages, joining Allergan (NYSE:AGN) CEO...
View ArticleClik here to view.
Endurance through criticism: The legendary career of Dr. John Simpson
Avinger executive chairman Dr. John Simpson Welcome to the Medsider interview series, a regular feature at MassDevice. All interviews are conducted by Scott Nelson, Founder of Medsider and Group...
View ArticleClik here to view.
Researchers develop targeted, photodynamic nanoparticles for tumor therapy
Researchers at the University of Massachusetts Medical School have developed photodynamic nanoparticles that can effectively target deep-tissue tumors. The team’s work was published in the Journal of...
View Article
